Article info
PDFClinical ethics
Psychotherapy, placebos, and informed consent
- Correspondence to Dr Garson Leder, Alden March Bioethics Institute, Albany Medical College, Albany, NY 12208, USA; leder.garson{at}gmail.com
Citation
Psychotherapy, placebos, and informed consent
Publication history
- Received May 16, 2020
- Revised June 19, 2020
- Accepted June 26, 2020
- First published August 20, 2020.
Online issue publication
June 24, 2021
Article Versions
- Previous version (24 June 2021).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.
Other content recommended for you
- How to obtain informed consent for psychotherapy: a reply to criticism
- Psychotherapy is still failing patients: revisiting informed consent—a response to Garson Leder
- Talking more about talking cures: cognitive behavioural therapy and informed consent
- Open therapy and its enemies
- Cost and outcome of behavioural activation versus cognitive behavioural therapy for depression (COBRA): a qualitative process evaluation
- Mediators and theories of change in psychotherapy with adolescents: a systematic review protocol
- All you need is cognitive behaviour therapy?
- Expectation focused and frequency enhanced cognitive behavioural therapy for patients with major depression (EFFECT): a study protocol of a randomised active-control trial
- Persistence of gastrointestinal symptoms in irritable bowel syndrome and ulcerative colitis: study protocol for a three-arm randomised controlled trial (SOMA.GUT-RCT)
- Fortnightly review: Cognitive behaviour therapy–clinical applications